Ysios Capital

What is Ysios Capital?

Ysios Capital is a venture capital firm that specializes in early-stage investments, focusing primarily on the BioTech and HealthTech sectors. With a keen interest in innovative companies, Ysios Capital positions itself as a pivotal supporter of ventures that aim to transform the healthcare industry through groundbreaking technology and research.

They offer financial backing and strategic guidance to ambitious entrepreneurs who aspire to make significant impact within the realms of biotechnology, medical devices, diagnostics, and digital health. By deploying capital in the early stages of company development, they nurture the growth of these startups, providing not just capital but also industry insights and network opportunities.

Ysios Capital invests in Pre-Seed and Seed rounds, with a minimum investment threshold of 1,000,000 and a maximum of 7,500,000, though they often find their sweet spot at the 1,000,000 investment level.

Managing assets worth 126,400,000, Ysios Capital leverages its resources to build a portfolio of companies that not only promise high growth potential but also the ability to deliver substantial advancements in health and wellness. They seek to be active partners to their investees, working closely to steer them towards success.

Ysios Capital's commitment to nurturing novel bio and health technologies makes them an important player in the venture capital landscape, aiming to generate both significant financial returns and societal health benefits.